Warmuth Markus Insider Profile
4 Followers
Warmuth Markus, President & CEO, Director at Monte Rosa Therapeutics, holds 605.47K shares in Monte Rosa Therapeutics (Ticker: GLUE). Most recently, Warmuth Markus Sold 8,000 shares of Monte Rosa Therapeutics on Apr 15, 2026 for an estimated value of $141.12K.
Warmuth Markus has not reported sufficient informative transactions and therefore cannot be ranked.
Time Frame
Compare to
Insider Roles
President & CEO, Director
Roles that Warmuth Markus holds in companies
Most Profitable Insider Trade
Currently, no data available
The most profitable trade made by Warmuth Markus
Warmuth Markus's Trading History
List of latest transactions for each holding click on a transaction to see Warmuth Markus's performance on stock
You May Also Like
Warmuth Markus insider profile FAQ
What is the percentage of profitable transactions made by Warmuth Markus?
The percentage of profitable transactions made by Warmuth Markus is ―.
What is the average return per transaction made by Warmuth Markus?
The average return per transaction made by Warmuth Markus is ―.
What stocks does Warmuth Markus hold?
Warmuth Markus holds: GLUE stocks.
What was Warmuth Markus’s latest transaction?
Warmuth Markus latest transaction was an Informative Sell of $141.12K.
What was Warmuth Markus's most profitable transaction?
Warmuth Markus’s most profitable transaction was an Uninformative Buy of stock on ―. The return on the trade was ―.
What is Warmuth Markus's role in Monte Rosa Therapeutics?
Warmuth Markus's role in Monte Rosa Therapeutics is President & CEO, Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.